SEC Claims Mass. Broker Lied To Short Drug Co. By $1.3M
The U.S. Securities and Exchange Commission on Wednesday sued a Massachusetts hedge fund adviser who allegedly drove down the price of San Diego-based Ligand Pharmaceuticals Inc. and bet against its stock...To view the full article, register now.
Already a subscriber? Click here to view full article